MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling. - Engelman, Jeffrey A.; Zejnullahu, Kreshnik; Mitsudomi, Tetsuya; Youngchul Song; Hyland, Courtney; Park, Joon Oh; Lindeman, Neal; Gale, Christopher-Michael; Xiaojun Zhao; Christensen, James; Kosaka, Takayuki; Holmes, Alison J.; et al. (Science (pre-March 2025), 2007)